Frontlight ResearchEarly access
Neuromyelitis optica (NMOSD) trials in Italy
5 of 8 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 14 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleRegistry of Patients With AQP4+ NMOSD Treated With Alexion C5 Inhibitor Therapies
- Where
- Naples
- Age
- 18 years and over
- People
- 200 worldwide
- Run by
- Alexion Pharmaceuticals, Inc.
See details and how to joinNCT05966467 - No phaseEnrolling by invitationThe Italian Multiple Sclerosis and Related Disorders Register
- Where
- Genova
- People
- 96,000
- Run by
- Fondazione Italiana Sclerosi Multipla
See details and how to joinNCT07636876 - No phaseTaking peopleStudy of Ultomiris® (Ravulizumab) Safety in Pregnancy
- Where
- Rome
- People
- 75 worldwide
- Run by
- Alexion Pharmaceuticals, Inc.
See details and how to joinNCT06312644 - No phaseNot yet taking people in ItalyAnticipating Irreversible Disability in Neuromyelitis Optica Spectrum Disorder: a Study to Assess Disease Activity in Apparently Stable Patients
- Where
- Milan
- Age
- 18 years and over
- People
- 50
- Run by
- IRCCS San Raffaele
See details and how to joinNCT07526298 - No phaseTaking peopleAnalysis of the Role of AIRE in Autoimmune Neurological Diseases Associated With Autoantibodies
- Where
- Roma
- Age
- 18 years and over
- People
- 40
- Run by
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
See details and how to joinNCT06941584